quantit
revers
transcript
polymeras
chain
reaction
rtqpcr
assay
gold
standard
recommend
test
acut
infect
use
center
diseas
control
prevent
cdc
sever
compani
emerg
use
author
eua
assay
mani
pcrbase
molecular
assay
extract
step
routin
use
part
protocol
step
take
signific
amount
time
labor
especi
extract
perform
manual
long
assay
time
partli
caus
slow
sampl
prepar
step
creat
larg
backlog
test
patient
sampl
suspect
use
flu
rsv
clinic
specimen
collect
evid
rtqpcr
assay
perform
directli
patient
sampl
materi
nasal
swab
immers
viru
transport
medium
vtm
without
rna
extract
step
also
use
approach
test
direct
detect
refer
materi
spike
vtm
data
preliminari
suggest
use
microlit
untreat
sampl
still
lead
sensit
test
result
rna
extract
step
omit
without
significantli
affect
clinic
sensit
turnaround
time
test
backlog
current
experi
reduc
drastic
next
confirm
find
use
patient
sampl
sampl
prepar
step
gener
timeconsum
regardless
whether
done
manual
autom
addit
current
shortag
recommend
viral
rna
extract
kit
need
center
diseas
control
prevent
cdc
rtqpcr
assay
diagnos
studi
develop
rapid
protocol
influenza
inf
respiratori
syncyti
viru
rsv
diagnost
investig
feasibl
omit
sampl
prepar
step
expedit
test
without
significantli
impact
test
sensit
use
inf
rsv
clinic
specimen
success
perform
rtqpcr
reaction
simpli
ad
microlit
unprocess
sampl
viral
transport
medium
vtm
directli
rtqpcr
assay
master
mix
test
approach
use
plasmid
seracar
accuplex
refer
materi
first
test
feasibl
use
small
amount
sampl
rtqpcr
reaction
use
aerosol
gener
vial
spray
sampl
uncap
pcr
tube
materi
vial
contain
influenza
infa
influenza
b
infb
rsv
clinic
specimen
swab
vtm
spray
pcr
tube
contain
primer
probe
set
target
infa
infb
rsv
rnasep
rp
master
mix
prior
cap
tube
perform
rtqpcr
fig
show
posit
pcr
signal
respect
tube
nonspecif
amplif
though
unprocess
spray
sampl
higher
ct
valu
infa
infb
rsv
respect
correspond
extract
rna
templat
sampl
infa
infb
rsv
import
note
abl
detect
low
viral
load
sampl
ct
less
sampl
enter
tube
measur
analyt
balanc
influenza
b
rsv
clinic
specimen
dilut
time
vtm
mimic
low
viral
load
sampl
spray
row
fourwel
pcr
tube
contain
infa
infb
rsv
rnasep
rp
primersprob
infa
infb
rsv
probe
tag
fam
dye
rp
probe
tag
calfluor
dye
ntc
b
infa
clinic
specimen
spray
c
infb
clinic
specimen
spray
rsv
clinic
specimen
spray
insert
imag
pcr
tube
taken
blue
led
illumin
orang
len
filter
captur
fam
dye
fluoresc
test
extent
pcr
inhibit
exert
flu
specimen
vtm
use
clinic
sampl
discoveri
life
scienc
biospecimen
repositori
unprocess
sampl
directli
spike
master
mix
infa
primer
reaction
mix
fig
extract
templat
promega
maxwel
devic
sampl
also
amplifi
along
unprocess
sampl
ad
unprocess
sampl
improv
reduc
ct
valu
ct
differ
extract
templat
input
eluat
unprocess
sampl
minim
vs
respect
ad
untreat
sampl
result
high
ct
data
shown
mean
inhibitori
effect
outweigh
benefit
copi
target
reaction
next
test
whether
rna
detect
directli
spike
sampl
nonrepl
recombin
viru
particl
seracar
accuplex
refer
materi
vtm
master
mix
without
extract
step
viru
particl
mix
vtm
get
final
concentr
copi
per
ml
differ
amount
mock
clinic
sampl
spike
master
mix
contain
cdc
recommend
rtqpcr
diagnost
panel
primer
pcr
reaction
though
note
primer
recent
remov
cdc
purifi
nucleic
acid
templat
isol
promega
maxwel
devic
also
amplifi
ct
differ
purifi
templat
directli
spike
clinic
sampl
ie
minim
ccbynd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
accuplex
refer
materi
process
promega
maxwel
devic
use
cartridg
elut
elut
buffer
extract
templat
ad
master
mix
rtqpcr
amplif
carri
biorad
thermal
cycler
along
reaction
unprocess
sampl
shown
fig
rna
directli
spike
sampl
success
detect
rtqpcr
reaction
without
nucleic
acid
extract
step
target
shown
vtm
accuplex
mix
use
reaction
exert
major
inhibit
pcr
amplif
averag
ct
valu
still
less
cycl
consid
common
cut
templat
copiesreact
cycl
lower
result
untreat
sampl
copi
reaction
fig
specul
seracar
matrix
contain
trisbuff
salin
glycerol
antimicrobi
agent
human
protein
could
reason
notic
pcr
inhibit
also
test
vtm
mix
plasmid
purchas
integr
dna
technolog
inc
use
rtqpcr
plasmid
use
posit
control
cdc
rtqpcr
assay
posit
control
plasmid
mix
vtm
mix
use
rtqpcr
reaction
rtqpcr
result
show
ct
valu
control
without
vtm
vtm
mix
reaction
contain
copiesreact
similar
three
target
tabl
also
test
copi
plasmid
use
rtqpcr
gave
ct
valu
data
shown
mean
direct
spike
higher
concentr
genom
copi
vtm
major
pcr
inhibitori
effect
reaction
target
concentr
high
tabl
therefor
like
specimen
higher
viral
load
could
also
detect
rtqpcr
without
need
rna
extract
step
plasmid
vtm
show
pcr
inhibit
compar
plasmid
alon
cdc
posit
control
plasmid
idt
dilut
vtm
te
buffer
control
get
copi
per
ml
plasmid
vtm
te
buffer
ad
pcr
reaction
mix
target
gene
detect
ct
valu
control
plasmid
vtm
similar
indic
sampl
prepar
step
omit
high
viral
load
sampl
data
use
high
ct
low
ct
target
concentr
suggest
sinc
rtqpcr
highli
sensit
use
raw
sampl
minim
sampl
prepar
step
might
reduc
test
sensit
patient
tend
higher
viral
load
also
effici
extract
method
tend
drop
significantli
low
target
concentr
process
numer
wash
step
therefor
nucleic
acid
loss
extract
step
may
hurt
limit
detect
studi
patient
specimen
higher
number
sampl
need
confirm
preliminari
result
report
use
untreat
sampl
viabl
option
pandem
accuplex
refer
materi
seracar
contain
conrepl
viral
particl
viral
particl
per
ml
mix
equal
volum
vtm
get
final
concentr
viral
particl
per
ml
microlit
contain
genom
materi
equival
posit
control
plasmid
cdc
recommend
obtain
integr
dna
technolog
dilut
te
buffer
stock
solut
ad
vtm
get
final
concentr
ccbynd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
copiesml
control
prepar
dilut
plasmid
stock
solut
te
buffer
vtm
te
buffer
work
solut
copi
reaction
ad
pcr
reaction
promega
maxwel
extract
perform
use
cartridg
promega
corpor
madison
wi
sampl
accuplex
influenza
ab
rsv
ad
cartridg
elut
elut
buffer
provid
kit
taqpath
multiplex
master
mix
use
rtqpcr
reaction
specif
primer
probe
tag
fam
final
concentr
primer
probe
set
influenza
b
rsv
reaction
nm
reaction
detect
target
gene
final
concentr
primer
nm
probe
nm
per
cdc
protocol
tabl
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
author
declar
conflict
interest
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
